Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa

This study is currently recruiting participants. (see Contacts and Locations)

Verified February 2017 by Dana-Farber Cancer Institute

Sponsor:

Information provided by (Responsible Party):

Nadine Tung, MD, Dana-Farber Cancer Institute

ClinicalTrials.gov Identifier:

NCT01670500

First received: August 16, 2012

Last updated: February 4, 2017

Last verified: February 2017

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2018
Estimated Primary Completion Date:	June 2018 (Final data collection date for primary outcome measure)